簡(jiǎn)介:甲磺酸去鐵胺,Deferoxamine mesylate是一種鐵螯合劑,可將游離鐵與穩(wěn)定的復(fù)合物結(jié)合,防止其發(fā)生化學(xué)反應(yīng)。
甲磺酸去鐵胺物理化學(xué)性質(zhì):
沸點(diǎn) |
966.9oC at 760 mmHg |
熔點(diǎn) |
148-149° |
分子式 |
C26H52N6O11S |
分子量 |
752.895 |
閃點(diǎn) |
538.5oC |
精確質(zhì)量 |
752.32959 |
PSA |
268.59 |
LogP |
2.989 |
外觀性狀 |
白色至灰白色粉末 |
蒸汽壓 |
0mmHg at 25°C |
儲(chǔ)存條件 |
2~10℃保存 |
水溶解性 |
H2O: 50 mg/mL |
甲磺酸去鐵胺詳細(xì)介紹:
中文名稱(chēng): |
甲磺酸去鐵胺 |
中文別名: |
甲磺酸去鐵胺;甲磺酸去鐵敏;甲磺酸除鐵靈;甲磺酸去鐵胺標(biāo)準(zhǔn)品;甲磺酸去鐵胺標(biāo)準(zhǔn)品(JP);去鐵銨;去鐵銨 USP標(biāo)準(zhǔn)品;去鐵胺甲磺酸鹽 EP標(biāo)準(zhǔn)品;去鐵胺甲磺酸酯;十一酸甘油三酯;云鐵胺甲磺酸酯;DEFEROX胺甲磺酸鹽;去鐵胺甲磺酸鹽;去鐵銨/去鐵敏 |
英文名稱(chēng): |
Deferoxamine mesylate |
英文別名: |
Deferoxamine mesylate;Deferoxamine mesylate salt;Deferoxamine (mesylate);EHNA;Deferoxamine Methanesulfonate;Desferrioxamine B mesylate;DFOM;DFOM,Deferoxamine methanesulfonate salt,Desferrioxamine mesylate salt;Deferoxamine methanesulfonate salt;Desferrioxamine mesylate salt;desferal;Prestwick_988;desferalmesylate;deferoxaminemesilate;deferoxaminebmesylate;DEFEROXAMINE MESYLATE;monomethanesulfonate(sa;desferrioxaminebmesylate;desferalmethanesulfonate |
CAS號(hào): |
138-14-7 |
分子式: |
C27H56N6O14S2 |
分子量: |
752.90 |
詳細(xì)描述: |
博飛美科提供138-14-7,甲磺酸去鐵胺,Deferoxamine mesylate,Perfemiker,上?,F(xiàn)貨。 Perfemiker,致力于提供高品質(zhì)、高性?xún)r(jià)比小分子化合物的產(chǎn)品。 Perfemiker小分子化合物大量庫(kù)存,提供超過(guò)2萬(wàn)種的抑制劑、激動(dòng)劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 鐵螯合劑,Deferoxamine mesylate是一種鐵螯合劑,可將游離鐵與穩(wěn)定的復(fù)合物結(jié)合,防止其發(fā)生化學(xué)反應(yīng)。 查詢(xún)關(guān)鍵詞:“138-14-7,甲磺酸去鐵胺,Deferoxamine mesylate,Perfemiker,上?,F(xiàn)貨”。 |
甲磺酸去鐵胺參考文獻(xiàn):
[1]. Li Y, et al. Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage. PLoS One. 2017 Mar 1;12(3):e0172784
[2]. Duscher D, et al. Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing. Plast Reconstr Surg. 2017 Mar;139(3):695e-706e
[3]. Wang G, et al. In vitro assessment of deferoxamine on mesenchymal stromal cells from tumor and bone marrow. Environ Toxicol Pharmacol. 2017 Jan;49:58-64
[4]. Wahl EA, et al. VEGF released by deferoxamine preconditioned mesenchymal stem cells seeded on collagen-GAG substrates enhances neovascularization. Sci Rep. 2016 Nov 10;6:36879
[5]. Fine JM, et al. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. Neurosci Lett. 2015 Jan 1;584:362-7